` BINV (BioInvent International AB) vs OMX Stockholm 30 Comparison - Alpha Spread

BINV
vs
OMX Stockholm 30

Over the past 12 months, BINV has significantly outperformed OMX Stockholm 30, delivering a return of 50% compared to the OMX Stockholm 30's 9% drop.

Stocks Performance
BINV vs OMX Stockholm 30

Loading
BINV
OMX Stockholm 30
Add Stock

Performance Gap
BINV vs OMX Stockholm 30

Loading
BINV
OMX Stockholm 30
Difference

Performance By Year
BINV vs OMX Stockholm 30

Loading
BINV
OMX Stockholm 30
Add Stock

Competitors Performance
BioInvent International AB vs Peers

OMX Stockholm 30
BINV
ABBV
AMGN
GILD
VRTX
Add Stock

BioInvent International AB
Glance View

Market Cap
1.8B SEK
Industry
Biotechnology

BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.

BINV Intrinsic Value
84.47 SEK
Undervaluation 67%
Intrinsic Value
Price
B
Back to Top